High sensitivity Troponin-T for prediction of adverse events in patients with COVID-19.
Nikhil SinghRajeev K AnchanStephanie A BesserMark N BelkinMark D CruzLinda LeeDongbo YuNatasha MehtaAnn B NguyenFrancis J AlenghatPublished in: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals (2020)
In patients hospitalized with COVID-19, hs-TnT identifies patients at high risk for adverse in-hospital events, and trends of hs-TnT over time, particularly during the first day, provide additional prognostic information.